ARTICLE | Clinical News
Augment Injectable Bone Graft regulatory update
November 12, 2012 8:00 AM UTC
BioMimetic disclosed in its 3Q12 earnings that it submitted a Device License Application (DLA) to Health Canada for Augment Injectable Bone Graft. In June, BioMimetic reported data from a Canadian piv...